These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38394731)
1. Lycorine and homolycorine derivatives for chemo-sensitizing resistant human ovarian adenocarcinoma cells. Sancha SAR; Dobiasová S; Nejedlý T; Strnad O; Viktorová J; Ferreira MU Phytomedicine; 2024 Apr; 126():155460. PubMed ID: 38394731 [TBL] [Abstract][Full Text] [Related]
2. Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells. Sancha SAR; Szemerédi N; Spengler G; Ferreira MU Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768386 [TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells. Bharathiraja P; Cardoso DSP; Rajendra Prasad N; Mulhovo S; Lakra DS; Ferreira MU J Biochem Mol Toxicol; 2023 Sep; 37(9):e23421. PubMed ID: 37345739 [TBL] [Abstract][Full Text] [Related]
4. Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells. Abdelhafiz AHA; Serya RAT; Lasheen DS; Wang N; Sobeh M; Wink M; Abouzid KAM J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2710-2724. PubMed ID: 36168121 [TBL] [Abstract][Full Text] [Related]
5. Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells. Cardoso DSP; Kincses A; Nové M; Spengler G; Mulhovo S; Aires-de-Sousa J; Dos Santos DJVA; Ferreira MU Eur J Med Chem; 2021 Jan; 210():112985. PubMed ID: 33189435 [TBL] [Abstract][Full Text] [Related]
7. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
8. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650 [TBL] [Abstract][Full Text] [Related]
9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo. Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682 [TBL] [Abstract][Full Text] [Related]
10. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
12. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence. Morsy MA; Kandeel M; Ibrahim ARN; Abdel-Gaber SA; Jacob S; Venugopala KN; Shinu P; El-Daly M Molecules; 2022 Oct; 27(21):. PubMed ID: 36364209 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance. Wang C; Zhang J; Wei X; Yang M; Ma W; Yu R; Liu M; Jiang T Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233508 [TBL] [Abstract][Full Text] [Related]
14. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
15. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells. Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405 [TBL] [Abstract][Full Text] [Related]
16. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H; Krstin S; Wink M Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981 [TBL] [Abstract][Full Text] [Related]
17. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
18. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells. Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]